Old Web
English
Sign In
Acemap
>
authorDetail
>
Jane Kendrew
Jane Kendrew
Vascular endothelial growth factor
Immunology
Tyrosine kinase
Vascular endothelial growth inhibitor
Endothelial stem cell
3
Papers
422
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts
2007
Molecular Cancer Therapeutics
Neil R. Smith
Neil H. James
Oakley I
A Wainwright
Copley C
Jane Kendrew
Womersley Lm
Juliane M. Jürgensmeier
Simon T. Barry
Show All
Source
Cite
Save
Citations (54)
Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis.
2000
Laboratory Investigation
Jadwiga M. Miotla
Rose A. Maciewicz
Jane Kendrew
Marc Feldmann
Ewa Paleolog
Show All
Source
Cite
Save
Citations (149)
Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors.
1999
Journal of Medicinal Chemistry
Laurent Francois Andre Hennequin
Andrew Peter Thomas
Craig Johnstone
Elaine Sophie Elizabeth Stokes
Patrick Ple
Lohmann Jj
Donald J. Ogilvie
Michael Dukes
Jon Owen Curwen
Jane Kendrew
Lambert-van der Brempt C
Show All
Source
Cite
Save
Citations (219)
1